Devintec Sagl
Lugano, CH· latest recorded location
DEVINTEC SAGL is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
By publication year.
Technology areas
Share of 6 documents
Recent patents
- Compositions for treating autoimmune arthritis31 Dec 2024US 12,178,844 B2
- Compositions for the treatment of intestinal disorders22 Sep 2020US 10,780,146 B2
- Compositions for treating autoimmune arthritis1 May 2025US 2025/0134953 A1
- Compositions for treating autoimmune arthritis24 Apr 2025US 2025/0127848 A1
- Compositions for treating autoimmune arthritis21 Mar 2024US 2024/0091308 A1
- Compositions for the treatment of intestinal disorders11 Jul 2019US 2019/0209647 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.